Bellerophon Therapeutics, Inc.
USD0.01
-0.01 (-36.84%)
CEO
Craig R. Jalbert CIRA
IPO Date
2015-02-13
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$0.01
Prev. Close
$0.02
Day Low
$0.01
Day High
$0.01
52W Low
$0.01
52W High
$0.10
Market Cap
$0.00B
Volume
0.00M
| -1.7 |
| 31 Dec 2020 | FY | 0.0% | 0.0% | -64.7% | -49.2% | 0.04 | 4.61 | -2.1 |
| 31 Dec 2019 | FY | 0.0% | 0.0% | -369.5% | -101.2% | 0.65 | 1.37 | -1.8 |
| 31 Dec 2018 | FY | 0.0% | 0.0% | 73.0% | 15.3% | 0.00 | 2.31 | 18.5 |
| 31 Dec 2017 | FY | 0.0% | 0.0% | 2113.3% | -148.9% | 0.00 | 5.03 | -1.8 |
| 31 Dec 2016 | FY | 0.0% | 0.0% | -132.4% | -80.2% | 0.00 | 4.08 | -2.5 |
| 31 Dec 2015 | FY | 0.0% | 0.0% | -153.1% | -121.0% | 0.00 | 3.65 | -7.2 |
| 31 Dec 2014 | FY | 0.0% | 0.0% | -260.2% | -178.7% | 0.00 | 2.65 | -26.8 |
| 31 Dec 2013 | FY | 0.0% | 0.0% | 394.0% | -1705.1% | 0.00 | 0.11 | -28.0 |
| -0.4 |
| 31 Mar 2023 | Q1 | 100.0% | 50.0% | 26.6% | 17.7% | 0.00 | 2.94 | 7.2 |
| 31 Dec 2022 | Q4 | 0.0% | 0.0% | -293.3% | -93.7% | 0.08 | 1.40 | -0.3 |
| 30 Sept 2022 | Q3 | 0.0% | 0.0% | -68.2% | -40.2% | 0.05 | 2.33 | -0.5 |
| 30 Jun 2022 | Q2 | 0.0% | 0.0% | -33.4% | -23.2% | 0.05 | 3.12 | -0.7 |
| 31 Mar 2022 | Q1 | 0.0% | 0.0% | -34.9% | -25.9% | 0.05 | 3.69 | -1.0 |
| 31 Dec 2021 | Q4 | 0.0% | 0.0% | -19.8% | -15.9% | 0.04 | 5.04 | -1.7 |
| 30 Sept 2021 | Q3 | 0.0% | 0.0% | -18.0% | -14.8% | 0.04 | 5.80 | -2.1 |
| 30 Jun 2021 | Q2 | 0.0% | 0.0% | -11.3% | -9.1% | 0.04 | 5.67 | -3.4 |